APO Research
Talk to an analyst

APO RESEARCH · REPORT

GABAA Receptor Agonists

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global GABAA Receptor Agonists Industry Growth and Trends Forecast to 2032

20 December 2025127 pages

Choose your research edition.

Industry ResearchGABAA Receptor Agonists Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal GABAA Receptor Agonists Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal GABAA Receptor Agonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GABAA Receptor Agonists Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal GABAA Receptor Agonists Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global GABAA Receptor Agonists market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for GABAA Receptor Agonists is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for GABAA Receptor Agonists is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for GABAA Receptor Agonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of GABAA Receptor Agonists include Takeda, Teva, Sun Pharma, Shanghai Pharmaceuticals Holding, Sandoz, Sanofi, Novartis, Mylan and Roche, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global GABAA Receptor Agonists market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The GABAA Receptor Agonists market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global GABAA Receptor Agonists market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to GABAA Receptor Agonists.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global GABAA Receptor Agonists market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

GABAA Receptor Agonists Market by Company

Takeda

Teva

Sun Pharma

Shanghai Pharmaceuticals Holding

Sandoz

Sanofi

Novartis

Mylan

Roche

Pfizer

Huazhong Pharmaceutical

Sichuan HaiscoPharmaceuical

GSK

Fresenius Kabi

Changzhou Siyao Pharmaceutical

AstraZeneca

WG Critical Care

Viatris

Torrent Pharma

SAGE Therapeutics

Neurelis

Hikma

CHEPLAPHARM

Apotex

Akorn

GABAA Receptor Agonists Segment by Type

BZDs

Non-BZDs

GABAA Receptor Agonists Segment by Application

Epilepsy

Anxiety

Neuropathic Pain

Insomnia

Other

GABAA Receptor Agonists Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GABAA Receptor Agonists market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GABAA Receptor Agonists and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GABAA Receptor Agonists.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of GABAA Receptor Agonists manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of GABAA Receptor Agonists in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of BZDs Table 2. Major Company of Non-BZDs Table 3. Global GABAA Receptor Agonists Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global GABAA Receptor Agonists Sales by Type (2021-2026) & (k units) Table 5. Global GABAA Receptor Agonists Sales Market Share in Volume by Type (2021-2026) Table 6. Global GABAA Receptor Agonists Sales by Type (2021-2026) & (US$ Million) Table 7. Global GABAA Receptor Agonists Sales Market Share in Value by Type (2021-2026) Table 8. Global GABAA Receptor Agonists Price by Type (2021-2026) & (US$/unit) Table 9. Global GABAA Receptor Agonists Sales by Type (2027-2032) & (k units) Table 10. Global GABAA Receptor Agonists Sales Market Share in Volume by Type (2027-2032) Table 11. Global GABAA Receptor Agonists Sales by Type (2027-2032) & (US$ Million) Table 12. Global GABAA Receptor Agonists Sales Market Share in Value by Type (2027-2032) Table 13. Global GABAA Receptor Agonists Price by Type (2027-2032) & (US$/unit) Table 14. North America GABAA Receptor Agonists Sales by Type (2021-2026) & (k units) Table 15. North America GABAA Receptor Agonists Sales by Type (2021-2026) & (US$ Million) Table 16. Europe GABAA Receptor Agonists Sales by Type (2021-2026) & (k units) Table 17. Europe GABAA Receptor Agonists Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific GABAA Receptor Agonists Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific GABAA Receptor Agonists Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America GABAA Receptor Agonists Sales by Type (2021-2026) & (k units) Table 21. Latin America GABAA Receptor Agonists Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa GABAA Receptor Agonists Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa GABAA Receptor Agonists Sales by Type (2021-2026) & (US$ Million) Table 24. GABAA Receptor Agonists Industry Trends Table 25. GABAA Receptor Agonists Industry Drivers Table 26. GABAA Receptor Agonists Industry Opportunities and Challenges Table 27. GABAA Receptor Agonists Industry Restraints Table 28. Global GABAA Receptor Agonists Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global GABAA Receptor Agonists Revenue Market Share by Company (2021-2026) Table 30. Global GABAA Receptor Agonists Sales by Company (2021-2026) & (k units) Table 31. Global GABAA Receptor Agonists Sales Share by Company (2021-2026) Table 32. Global GABAA Receptor Agonists Market Price by Company (2021-2026) & (US$/unit) Table 33. Global GABAA Receptor Agonists Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global GABAA Receptor Agonists Major Company Production Sites and Headquarters Table 35. Global GABAA Receptor Agonists Company, Product Type & Application Table 36. Global GABAA Receptor Agonists Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global GABAA Receptor Agonists by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global GABAA Receptor Agonists Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global GABAA Receptor Agonists Sales by Region (2021-2026) & (k units) Table 41. Global GABAA Receptor Agonists Sales Market Share in Volume by Region (2021-2026) Table 42. Global GABAA Receptor Agonists Sales by Region (2021-2026) & (US$ Million) Table 43. Global GABAA Receptor Agonists Sales Market Share in Value by Region (2021-2026) Table 44. Global GABAA Receptor Agonists Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global GABAA Receptor Agonists Sales by Region (2027-2032) & (k units) Table 46. Global GABAA Receptor Agonists Sales Market Share in Volume by Region (2027-2032) Table 47. Global GABAA Receptor Agonists Sales by Region (2027-2032) & (US$ Million) Table 48. Global GABAA Receptor Agonists Sales Market Share in Value by Region (2027-2032) Table 49. Global GABAA Receptor Agonists Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global GABAA Receptor Agonists Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global GABAA Receptor Agonists Sales by Application (2021-2026) & (k units) Table 52. Global GABAA Receptor Agonists Sales Market Share in Volume by Application (2021-2026) Table 53. Global GABAA Receptor Agonists Sales by Application (2021-2026) & (US$ Million) Table 54. Global GABAA Receptor Agonists Sales Market Share in Value by Application (2021-2026) Table 55. Global GABAA Receptor Agonists Price by Application (2021-2026) & (US$/unit) Table 56. Global GABAA Receptor Agonists Sales by Application (2027-2032) & (k units) Table 57. Global GABAA Receptor Agonists Sales Market Share in Volume by Application (2027-2032) Table 58. Global GABAA Receptor Agonists Sales by Application (2027-2032) & (US$ Million) Table 59. Global GABAA Receptor Agonists Sales Market Share in Value by Application (2027-2032) Table 60. Global GABAA Receptor Agonists Price by Application (2027-2032) & (US$/unit) Table 61. North America GABAA Receptor Agonists Sales by Application (2021-2026) & (k units) Table 62. North America GABAA Receptor Agonists Sales by Application (2021-2026) & (US$ Million) Table 63. Europe GABAA Receptor Agonists Sales by Application (2021-2026) & (k units) Table 64. Europe GABAA Receptor Agonists Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific GABAA Receptor Agonists Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific GABAA Receptor Agonists Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America GABAA Receptor Agonists Sales by Application (2021-2026) & (k units) Table 68. Latin America GABAA Receptor Agonists Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa GABAA Receptor Agonists Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa GABAA Receptor Agonists Sales by Application (2021-2026) & (US$ Million) Table 71. Takeda Company Information Table 72. Takeda Business Overview Table 73. Takeda GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Takeda GABAA Receptor Agonists Product Portfolio Table 75. Takeda Recent Development Table 76. Teva Company Information Table 77. Teva Business Overview Table 78. Teva GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Teva GABAA Receptor Agonists Product Portfolio Table 80. Teva Recent Development Table 81. Sun Pharma Company Information Table 82. Sun Pharma Business Overview Table 83. Sun Pharma GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Sun Pharma GABAA Receptor Agonists Product Portfolio Table 85. Sun Pharma Recent Development Table 86. Shanghai Pharmaceuticals Holding Company Information Table 87. Shanghai Pharmaceuticals Holding Business Overview Table 88. Shanghai Pharmaceuticals Holding GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Shanghai Pharmaceuticals Holding GABAA Receptor Agonists Product Portfolio Table 90. Shanghai Pharmaceuticals Holding Recent Development Table 91. Sandoz Company Information Table 92. Sandoz Business Overview Table 93. Sandoz GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Sandoz GABAA Receptor Agonists Product Portfolio Table 95. Sandoz Recent Development Table 96. Sanofi Company Information Table 97. Sanofi Business Overview Table 98. Sanofi GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Sanofi GABAA Receptor Agonists Product Portfolio Table 100. Sanofi Recent Development Table 101. Novartis Company Information Table 102. Novartis Business Overview Table 103. Novartis GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Novartis GABAA Receptor Agonists Product Portfolio Table 105. Novartis Recent Development Table 106. Mylan Company Information Table 107. Mylan Business Overview Table 108. Mylan GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Mylan GABAA Receptor Agonists Product Portfolio Table 110. Mylan Recent Development Table 111. Roche Company Information Table 112. Roche Business Overview Table 113. Roche GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Roche GABAA Receptor Agonists Product Portfolio Table 115. Roche Recent Development Table 116. Pfizer Company Information Table 117. Pfizer Business Overview Table 118. Pfizer GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Pfizer GABAA Receptor Agonists Product Portfolio Table 120. Pfizer Recent Development Table 121. Huazhong Pharmaceutical Company Information Table 122. Huazhong Pharmaceutical Business Overview Table 123. Huazhong Pharmaceutical GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Huazhong Pharmaceutical GABAA Receptor Agonists Product Portfolio Table 125. Huazhong Pharmaceutical Recent Development Table 126. Sichuan HaiscoPharmaceuical Company Information Table 127. Sichuan HaiscoPharmaceuical Business Overview Table 128. Sichuan HaiscoPharmaceuical GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Sichuan HaiscoPharmaceuical GABAA Receptor Agonists Product Portfolio Table 130. Sichuan HaiscoPharmaceuical Recent Development Table 131. GSK Company Information Table 132. GSK Business Overview Table 133. GSK GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. GSK GABAA Receptor Agonists Product Portfolio Table 135. GSK Recent Development Table 136. Fresenius Kabi Company Information Table 137. Fresenius Kabi Business Overview Table 138. Fresenius Kabi GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. Fresenius Kabi GABAA Receptor Agonists Product Portfolio Table 140. Fresenius Kabi Recent Development Table 141. Changzhou Siyao Pharmaceutical Company Information Table 142. Changzhou Siyao Pharmaceutical Business Overview Table 143. Changzhou Siyao Pharmaceutical GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 144. Changzhou Siyao Pharmaceutical GABAA Receptor Agonists Product Portfolio Table 145. Changzhou Siyao Pharmaceutical Recent Development Table 146. AstraZeneca Company Information Table 147. AstraZeneca Business Overview Table 148. AstraZeneca GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 149. AstraZeneca GABAA Receptor Agonists Product Portfolio Table 150. AstraZeneca Recent Development Table 151. WG Critical Care Company Information Table 152. WG Critical Care Business Overview Table 153. WG Critical Care GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 154. WG Critical Care GABAA Receptor Agonists Product Portfolio Table 155. WG Critical Care Recent Development Table 156. Viatris Company Information Table 157. Viatris Business Overview Table 158. Viatris GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 159. Viatris GABAA Receptor Agonists Product Portfolio Table 160. Viatris Recent Development Table 161. Torrent Pharma Company Information Table 162. Torrent Pharma Business Overview Table 163. Torrent Pharma GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 164. Torrent Pharma GABAA Receptor Agonists Product Portfolio Table 165. Torrent Pharma Recent Development Table 166. SAGE Therapeutics Company Information Table 167. SAGE Therapeutics Business Overview Table 168. SAGE Therapeutics GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 169. SAGE Therapeutics GABAA Receptor Agonists Product Portfolio Table 170. SAGE Therapeutics Recent Development Table 171. Neurelis Company Information Table 172. Neurelis Business Overview Table 173. Neurelis GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 174. Neurelis GABAA Receptor Agonists Product Portfolio Table 175. Neurelis Recent Development Table 176. Hikma Company Information Table 177. Hikma Business Overview Table 178. Hikma GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 179. Hikma GABAA Receptor Agonists Product Portfolio Table 180. Hikma Recent Development Table 181. CHEPLAPHARM Company Information Table 182. CHEPLAPHARM Business Overview Table 183. CHEPLAPHARM GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 184. CHEPLAPHARM GABAA Receptor Agonists Product Portfolio Table 185. CHEPLAPHARM Recent Development Table 186. Apotex Company Information Table 187. Apotex Business Overview Table 188. Apotex GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 189. Apotex GABAA Receptor Agonists Product Portfolio Table 190. Apotex Recent Development Table 191. Akorn Company Information Table 192. Akorn Business Overview Table 193. Akorn GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 194. Akorn GABAA Receptor Agonists Product Portfolio Table 195. Akorn Recent Development Table 196. North America GABAA Receptor Agonists Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 197. North America GABAA Receptor Agonists Sales by Country (2021-2026) & (k units) Table 198. North America GABAA Receptor Agonists Sales Market Share by Country (2021-2026) Table 199. North America GABAA Receptor Agonists Sales Forecast by Country (2027-2032) & (k units) Table 200. North America GABAA Receptor Agonists Sales Market Share Forecast by Country (2027-2032) Table 201. North America GABAA Receptor Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. North America GABAA Receptor Agonists Market Size by Country (2021-2026) & (US$ Million) Table 203. North America GABAA Receptor Agonists Market Share by Country (2021-2026) Table 204. North America GABAA Receptor Agonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. North America GABAA Receptor Agonists Market Share Forecast by Country (2027-2032) Table 206. Europe GABAA Receptor Agonists Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 207. Europe GABAA Receptor Agonists Sales by Country (2021-2026) & (k units) Table 208. Europe GABAA Receptor Agonists Sales Market Share by Country (2021-2026) Table 209. Europe GABAA Receptor Agonists Sales Forecast by Country (2027-2032) & (k units) Table 210. Europe GABAA Receptor Agonists Sales Market Share Forecast by Country (2027-2032) Table 211. Europe GABAA Receptor Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 212. Europe GABAA Receptor Agonists Market Size by Country (2021-2026) & (US$ Million) Table 213. Europe GABAA Receptor Agonists Market Share by Country (2021-2026) Table 214. Europe GABAA Receptor Agonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 215. Europe GABAA Receptor Agonists Market Share Forecast by Country (2027-2032) Table 216. Asia-Pacific GABAA Receptor Agonists Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 217. Asia-Pacific GABAA Receptor Agonists Sales by Country (2021-2026) & (k units) Table 218. Asia-Pacific GABAA Receptor Agonists Sales Market Share by Country (2021-2026) Table 219. Asia-Pacific GABAA Receptor Agonists Sales Forecast by Country (2027-2032) & (k units) Table 220. Asia-Pacific GABAA Receptor Agonists Sales Market Share Forecast by Country (2027-2032) Table 221. Asia-Pacific GABAA Receptor Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 222. Asia-Pacific GABAA Receptor Agonists Market Size by Country (2021-2026) & (US$ Million) Table 223. Asia-Pacific GABAA Receptor Agonists Market Share by Country (2021-2026) Table 224. Asia-Pacific GABAA Receptor Agonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 225. Asia-Pacific GABAA Receptor Agonists Market Share Forecast by Country (2027-2032) Table 226. Latin America GABAA Receptor Agonists Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 227. Latin America GABAA Receptor Agonists Sales by Country (2021-2026) & (k units) Table 228. Latin America GABAA Receptor Agonists Sales Market Share by Country (2021-2026) Table 229. Latin America GABAA Receptor Agonists Sales Forecast by Country (2027-2032) & (k units) Table 230. Latin America GABAA Receptor Agonists Sales Market Share Forecast by Country (2027-2032) Table 231. Latin America GABAA Receptor Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 232. Latin America GABAA Receptor Agonists Market Size by Country (2021-2026) & (US$ Million) Table 233. Latin America GABAA Receptor Agonists Market Share by Country (2021-2026) Table 234. Latin America GABAA Receptor Agonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 235. Latin America GABAA Receptor Agonists Market Share Forecast by Country (2027-2032) Table 236. Middle East and Africa GABAA Receptor Agonists Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 237. Middle East and Africa GABAA Receptor Agonists Sales by Country (2021-2026) & (k units) Table 238. Middle East and Africa GABAA Receptor Agonists Sales Market Share by Country (2021-2026) Table 239. Middle East and Africa GABAA Receptor Agonists Sales Forecast by Country (2027-2032) & (k units) Table 240. Middle East and Africa GABAA Receptor Agonists Sales Market Share Forecast by Country (2027-2032) Table 241. Middle East and Africa GABAA Receptor Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 242. Middle East and Africa GABAA Receptor Agonists Market Size by Country (2021-2026) & (US$ Million) Table 243. Middle East and Africa GABAA Receptor Agonists Market Share by Country (2021-2026) Table 244. Middle East and Africa GABAA Receptor Agonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 245. Middle East and Africa GABAA Receptor Agonists Market Share Forecast by Country (2027-2032) Table 246. Key Raw Materials Table 247. Raw Materials Key Suppliers Table 248. GABAA Receptor Agonists Distributors List Table 249. GABAA Receptor Agonists Customers List Table 250. Research Programs/Design for This Report Table 251. Authors List of This Report Table 252. Secondary Sources Table 253. Primary Sources List of Figures Figure 1. GABAA Receptor Agonists Image Figure 2. Global GABAA Receptor Agonists Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GABAA Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 4. Global GABAA Receptor Agonists Sales (2021-2032) & (k units) Figure 5. BZDs Image Figure 6. Global BZDs Sales YoY Growth (2021-2032) & (k units) Figure 7. Non-BZDs Image Figure 8. Global Non-BZDs Sales YoY Growth (2021-2032) & (k units) Figure 9. Global GABAA Receptor Agonists Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global GABAA Receptor Agonists Market Share by Type 2025 VS 2032 Figure 11. North America GABAA Receptor Agonists Sales Market Share in Volume by Type in 2025 Figure 12. North America GABAA Receptor Agonists Sales Market Share in Value by Type in 2025 Figure 13. Europe GABAA Receptor Agonists Sales Market Share in Volume by Type in 2025 Figure 14. Europe GABAA Receptor Agonists Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific GABAA Receptor Agonists Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific GABAA Receptor Agonists Sales Market Share in Value by Type in 2025 Figure 17. Latin America GABAA Receptor Agonists Sales Market Share in Volume by Type in 2025 Figure 18. Latin America GABAA Receptor Agonists Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa GABAA Receptor Agonists Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa GABAA Receptor Agonists Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 GABAA Receptor Agonists Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Epilepsy Image Figure 24. Global Epilepsy Sales YoY Growth (2021-2032) & (k units) Figure 25. Anxiety Image Figure 26. Global Anxiety Sales YoY Growth (2021-2032) & (k units) Figure 27. Neuropathic Pain Image Figure 28. Global Neuropathic Pain Sales YoY Growth (2021-2032) & (k units) Figure 29. Insomnia Image Figure 30. Global Insomnia Sales YoY Growth (2021-2032) & (k units) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 33. Global GABAA Receptor Agonists Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global GABAA Receptor Agonists Market Share by Application 2025 VS 2032 Figure 35. North America GABAA Receptor Agonists Sales Market Share in Volume by Application in 2025 Figure 36. North America GABAA Receptor Agonists Sales Market Share in Value by Application in 2025 Figure 37. Europe GABAA Receptor Agonists Sales Market Share in Volume by Application in 2025 Figure 38. Europe GABAA Receptor Agonists Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific GABAA Receptor Agonists Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific GABAA Receptor Agonists Sales Market Share in Value by Application in 2025 Figure 41. Latin America GABAA Receptor Agonists Sales Market Share in Volume by Application in 2025 Figure 42. Latin America GABAA Receptor Agonists Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa GABAA Receptor Agonists Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa GABAA Receptor Agonists Sales Market Share in Value by Application in 2025 Figure 45. North America GABAA Receptor Agonists Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America GABAA Receptor Agonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America GABAA Receptor Agonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America GABAA Receptor Agonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe GABAA Receptor Agonists Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe GABAA Receptor Agonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe GABAA Receptor Agonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe GABAA Receptor Agonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific GABAA Receptor Agonists Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific GABAA Receptor Agonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific GABAA Receptor Agonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific GABAA Receptor Agonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America GABAA Receptor Agonists Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America GABAA Receptor Agonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America GABAA Receptor Agonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America GABAA Receptor Agonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa GABAA Receptor Agonists Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa GABAA Receptor Agonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa GABAA Receptor Agonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa GABAA Receptor Agonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. GABAA Receptor Agonists Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. GABAA Receptor Agonists Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • BZDs
  • Non-BZDs
Applications
  • Epilepsy
  • Anxiety
  • Neuropathic Pain
  • Insomnia
  • Other
Companies covered
  • Takeda
  • Teva
  • Sun Pharma
  • Shanghai Pharmaceuticals Holding
  • Sandoz
  • Sanofi
  • Novartis
  • Mylan
  • Roche
  • Pfizer
  • Huazhong Pharmaceutical
  • Sichuan HaiscoPharmaceuical
  • GSK
  • Fresenius Kabi
  • Changzhou Siyao Pharmaceutical
  • AstraZeneca
  • WG Critical Care
  • Viatris
  • Torrent Pharma
  • SAGE Therapeutics
  • Neurelis
  • Hikma
  • CHEPLAPHARM
  • Apotex
  • Akorn

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global GABAA Receptor Agonists Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global GABAA Receptor Agonists Sales Estimates and Forecasts (2021-2032)
  5. 1.3 GABAA Receptor Agonists Market by Type
  6. 1.3.1 BZDs
  7. 1.3.2 Non-BZDs
  8. 1.4 Global GABAA Receptor Agonists Market Size by Type
  9. 1.4.1 Global GABAA Receptor Agonists Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global GABAA Receptor Agonists Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global GABAA Receptor Agonists Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America GABAA Receptor Agonists Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe GABAA Receptor Agonists Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific GABAA Receptor Agonists Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America GABAA Receptor Agonists Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa GABAA Receptor Agonists Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 GABAA Receptor Agonists Industry Trends
  2. 2.2 GABAA Receptor Agonists Industry Drivers
  3. 2.3 GABAA Receptor Agonists Industry Opportunities and Challenges
  4. 2.4 GABAA Receptor Agonists Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by GABAA Receptor Agonists Revenue (2021-2026)
  2. 3.2 Global Top Players by GABAA Receptor Agonists Sales (2021-2026)
  3. 3.3 Global Top Players by GABAA Receptor Agonists Price (2021-2026)
  4. 3.4 Global GABAA Receptor Agonists Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global GABAA Receptor Agonists Major Company Production Sites & Headquarters
  6. 3.6 Global GABAA Receptor Agonists Company, Product Type & Application
  7. 3.7 Global GABAA Receptor Agonists Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global GABAA Receptor Agonists Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 GABAA Receptor Agonists Players Market Share by Revenue in 2025
  11. 3.8.3 2025 GABAA Receptor Agonists Tier 1, Tier 2, and Tier 3
4 GABAA Receptor Agonists Regional Status and Outlook
  1. 4.1 Global GABAA Receptor Agonists Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global GABAA Receptor Agonists Historic Market Size by Region
  3. 4.2.1 Global GABAA Receptor Agonists Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global GABAA Receptor Agonists Sales in Value by Region (2021-2026)
  5. 4.2.3 Global GABAA Receptor Agonists Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global GABAA Receptor Agonists Forecasted Market Size by Region
  7. 4.3.1 Global GABAA Receptor Agonists Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global GABAA Receptor Agonists Sales in Value by Region (2027-2032)
  9. 4.3.3 Global GABAA Receptor Agonists Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 GABAA Receptor Agonists by Application
  1. 5.1 GABAA Receptor Agonists Market by Application
  2. 5.1.1 Epilepsy
  3. 5.1.2 Anxiety
  4. 5.1.3 Neuropathic Pain
  5. 5.1.4 Insomnia
  6. 5.1.5 Other
  7. 5.2 Global GABAA Receptor Agonists Market Size by Application
  8. 5.2.1 Global GABAA Receptor Agonists Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global GABAA Receptor Agonists Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global GABAA Receptor Agonists Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America GABAA Receptor Agonists Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe GABAA Receptor Agonists Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific GABAA Receptor Agonists Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America GABAA Receptor Agonists Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa GABAA Receptor Agonists Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda GABAA Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda GABAA Receptor Agonists Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Teva
  8. 6.2.1 Teva Company Information
  9. 6.2.2 Teva Business Overview
  10. 6.2.3 Teva GABAA Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Teva GABAA Receptor Agonists Product Portfolio
  12. 6.2.5 Teva Recent Developments
  13. 6.3 Sun Pharma
  14. 6.3.1 Sun Pharma Company Information
  15. 6.3.2 Sun Pharma Business Overview
  16. 6.3.3 Sun Pharma GABAA Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sun Pharma GABAA Receptor Agonists Product Portfolio
  18. 6.3.5 Sun Pharma Recent Developments
  19. 6.4 Shanghai Pharmaceuticals Holding
  20. 6.4.1 Shanghai Pharmaceuticals Holding Company Information
  21. 6.4.2 Shanghai Pharmaceuticals Holding Business Overview
  22. 6.4.3 Shanghai Pharmaceuticals Holding GABAA Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Shanghai Pharmaceuticals Holding GABAA Receptor Agonists Product Portfolio
  24. 6.4.5 Shanghai Pharmaceuticals Holding Recent Developments
  25. 6.5 Sandoz
  26. 6.5.1 Sandoz Company Information
  27. 6.5.2 Sandoz Business Overview
  28. 6.5.3 Sandoz GABAA Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sandoz GABAA Receptor Agonists Product Portfolio
  30. 6.5.5 Sandoz Recent Developments
  31. 6.6 Sanofi
  32. 6.6.1 Sanofi Company Information
  33. 6.6.2 Sanofi Business Overview
  34. 6.6.3 Sanofi GABAA Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sanofi GABAA Receptor Agonists Product Portfolio
  36. 6.6.5 Sanofi Recent Developments
  37. 6.7 Novartis
  38. 6.7.1 Novartis Company Information
  39. 6.7.2 Novartis Business Overview
  40. 6.7.3 Novartis GABAA Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Novartis GABAA Receptor Agonists Product Portfolio
  42. 6.7.5 Novartis Recent Developments
  43. 6.8 Mylan
  44. 6.8.1 Mylan Company Information
  45. 6.8.2 Mylan Business Overview
  46. 6.8.3 Mylan GABAA Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Mylan GABAA Receptor Agonists Product Portfolio
  48. 6.8.5 Mylan Recent Developments
  49. 6.9 Roche
  50. 6.9.1 Roche Company Information
  51. 6.9.2 Roche Business Overview
  52. 6.9.3 Roche GABAA Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Roche GABAA Receptor Agonists Product Portfolio
  54. 6.9.5 Roche Recent Developments
  55. 6.10 Pfizer
  56. 6.10.1 Pfizer Company Information
  57. 6.10.2 Pfizer Business Overview
  58. 6.10.3 Pfizer GABAA Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Pfizer GABAA Receptor Agonists Product Portfolio
  60. 6.10.5 Pfizer Recent Developments
  61. 6.11 Huazhong Pharmaceutical
  62. 6.11.1 Huazhong Pharmaceutical Company Information
  63. 6.11.2 Huazhong Pharmaceutical Business Overview
  64. 6.11.3 Huazhong Pharmaceutical GABAA Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Huazhong Pharmaceutical GABAA Receptor Agonists Product Portfolio
  66. 6.11.5 Huazhong Pharmaceutical Recent Developments
  67. 6.12 Sichuan HaiscoPharmaceuical
  68. 6.12.1 Sichuan HaiscoPharmaceuical Company Information
  69. 6.12.2 Sichuan HaiscoPharmaceuical Business Overview
  70. 6.12.3 Sichuan HaiscoPharmaceuical GABAA Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Sichuan HaiscoPharmaceuical GABAA Receptor Agonists Product Portfolio
  72. 6.12.5 Sichuan HaiscoPharmaceuical Recent Developments
  73. 6.13 GSK
  74. 6.13.1 GSK Company Information
  75. 6.13.2 GSK Business Overview
  76. 6.13.3 GSK GABAA Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 GSK GABAA Receptor Agonists Product Portfolio
  78. 6.13.5 GSK Recent Developments
  79. 6.14 Fresenius Kabi
  80. 6.14.1 Fresenius Kabi Company Information
  81. 6.14.2 Fresenius Kabi Business Overview
  82. 6.14.3 Fresenius Kabi GABAA Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Fresenius Kabi GABAA Receptor Agonists Product Portfolio
  84. 6.14.5 Fresenius Kabi Recent Developments
  85. 6.15 Changzhou Siyao Pharmaceutical
  86. 6.15.1 Changzhou Siyao Pharmaceutical Company Information
  87. 6.15.2 Changzhou Siyao Pharmaceutical Business Overview
  88. 6.15.3 Changzhou Siyao Pharmaceutical GABAA Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Changzhou Siyao Pharmaceutical GABAA Receptor Agonists Product Portfolio
  90. 6.15.5 Changzhou Siyao Pharmaceutical Recent Developments
  91. 6.16 AstraZeneca
  92. 6.16.1 AstraZeneca Company Information
  93. 6.16.2 AstraZeneca Business Overview
  94. 6.16.3 AstraZeneca GABAA Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 AstraZeneca GABAA Receptor Agonists Product Portfolio
  96. 6.16.5 AstraZeneca Recent Developments
  97. 6.17 WG Critical Care
  98. 6.17.1 WG Critical Care Company Information
  99. 6.17.2 WG Critical Care Business Overview
  100. 6.17.3 WG Critical Care GABAA Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 WG Critical Care GABAA Receptor Agonists Product Portfolio
  102. 6.17.5 WG Critical Care Recent Developments
  103. 6.18 Viatris
  104. 6.18.1 Viatris Company Information
  105. 6.18.2 Viatris Business Overview
  106. 6.18.3 Viatris GABAA Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Viatris GABAA Receptor Agonists Product Portfolio
  108. 6.18.5 Viatris Recent Developments
  109. 6.19 Torrent Pharma
  110. 6.19.1 Torrent Pharma Company Information
  111. 6.19.2 Torrent Pharma Business Overview
  112. 6.19.3 Torrent Pharma GABAA Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Torrent Pharma GABAA Receptor Agonists Product Portfolio
  114. 6.19.5 Torrent Pharma Recent Developments
  115. 6.20 SAGE Therapeutics
  116. 6.20.1 SAGE Therapeutics Company Information
  117. 6.20.2 SAGE Therapeutics Business Overview
  118. 6.20.3 SAGE Therapeutics GABAA Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 SAGE Therapeutics GABAA Receptor Agonists Product Portfolio
  120. 6.20.5 SAGE Therapeutics Recent Developments
  121. 6.21 Neurelis
  122. 6.21.1 Neurelis Company Information
  123. 6.21.2 Neurelis Business Overview
  124. 6.21.3 Neurelis GABAA Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Neurelis GABAA Receptor Agonists Product Portfolio
  126. 6.21.5 Neurelis Recent Developments
  127. 6.22 Hikma
  128. 6.22.1 Hikma Company Information
  129. 6.22.2 Hikma Business Overview
  130. 6.22.3 Hikma GABAA Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Hikma GABAA Receptor Agonists Product Portfolio
  132. 6.22.5 Hikma Recent Developments
  133. 6.23 CHEPLAPHARM
  134. 6.23.1 CHEPLAPHARM Company Information
  135. 6.23.2 CHEPLAPHARM Business Overview
  136. 6.23.3 CHEPLAPHARM GABAA Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 CHEPLAPHARM GABAA Receptor Agonists Product Portfolio
  138. 6.23.5 CHEPLAPHARM Recent Developments
  139. 6.24 Apotex
  140. 6.24.1 Apotex Company Information
  141. 6.24.2 Apotex Business Overview
  142. 6.24.3 Apotex GABAA Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 Apotex GABAA Receptor Agonists Product Portfolio
  144. 6.24.5 Apotex Recent Developments
  145. 6.25 Akorn
  146. 6.25.1 Akorn Company Information
  147. 6.25.2 Akorn Business Overview
  148. 6.25.3 Akorn GABAA Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  149. 6.25.4 Akorn GABAA Receptor Agonists Product Portfolio
  150. 6.25.5 Akorn Recent Developments
7 North America by Country
  1. 7.1 North America GABAA Receptor Agonists Sales by Country
  2. 7.1.1 North America GABAA Receptor Agonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America GABAA Receptor Agonists Sales by Country (2021-2026)
  4. 7.1.3 North America GABAA Receptor Agonists Sales Forecast by Country (2027-2032)
  5. 7.2 North America GABAA Receptor Agonists Market Size by Country
  6. 7.2.1 North America GABAA Receptor Agonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America GABAA Receptor Agonists Market Size by Country (2021-2026)
  8. 7.2.3 North America GABAA Receptor Agonists Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe GABAA Receptor Agonists Sales by Country
  2. 8.1.1 Europe GABAA Receptor Agonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe GABAA Receptor Agonists Sales by Country (2021-2026)
  4. 8.1.3 Europe GABAA Receptor Agonists Sales Forecast by Country (2027-2032)
  5. 8.2 Europe GABAA Receptor Agonists Market Size by Country
  6. 8.2.1 Europe GABAA Receptor Agonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe GABAA Receptor Agonists Market Size by Country (2021-2026)
  8. 8.2.3 Europe GABAA Receptor Agonists Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific GABAA Receptor Agonists Sales by Country
  2. 9.1.1 Asia-Pacific GABAA Receptor Agonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific GABAA Receptor Agonists Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific GABAA Receptor Agonists Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific GABAA Receptor Agonists Market Size by Country
  6. 9.2.1 Asia-Pacific GABAA Receptor Agonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific GABAA Receptor Agonists Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific GABAA Receptor Agonists Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America GABAA Receptor Agonists Sales by Country
  2. 10.1.1 South America GABAA Receptor Agonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America GABAA Receptor Agonists Sales by Country (2021-2026)
  4. 10.1.3 South America GABAA Receptor Agonists Sales Forecast by Country (2027-2032)
  5. 10.2 South America GABAA Receptor Agonists Market Size by Country
  6. 10.2.1 South America GABAA Receptor Agonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America GABAA Receptor Agonists Market Size by Country (2021-2026)
  8. 10.2.3 South America GABAA Receptor Agonists Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa GABAA Receptor Agonists Sales by Country
  2. 11.1.1 Middle East and Africa GABAA Receptor Agonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa GABAA Receptor Agonists Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa GABAA Receptor Agonists Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa GABAA Receptor Agonists Market Size by Country
  6. 11.2.1 Middle East and Africa GABAA Receptor Agonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa GABAA Receptor Agonists Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa GABAA Receptor Agonists Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 GABAA Receptor Agonists Value Chain Analysis
  2. 12.1.1 GABAA Receptor Agonists Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 GABAA Receptor Agonists Production Mode & Process
  7. 12.2 GABAA Receptor Agonists Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 GABAA Receptor Agonists Distributors
  10. 12.2.3 GABAA Receptor Agonists Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst